Shionogi & Co., Ltd. (4507)

5,624.0
-53.0(-0.93%)
  • Volume:
    780,500
  • Bid/Ask:
    5,621.0/5,625.0
  • Day's Range:
    5,620.0 - 5,708.0

4507 Overview

Prev. Close
5,677
Day's Range
5,620-5,708
Revenue
297.18B
Open
5,640
52 wk Range
4,761-7,119
EPS
364.48
Volume
780,500
Market Cap
1.7T
Dividend (Yield)
110.00
(1.96%)
Average Volume (3m)
1,093,794
P/E Ratio
15.43
Beta
0.99
1-Year Change
-19.68%
Shares Outstanding
301,463,721
Next Earnings Date
01 Aug 2021
What is your sentiment on Shionogi & Co., Ltd.?
or
Market is currently closed. Voting is open during market hours.

Shionogi & Co., Ltd. News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellSell
SummaryStrong SellStrong SellStrong SellStrong SellSell

Shionogi & Co., Ltd. Company Profile

Shionogi & Co., Ltd. Company Profile

Employees
5222
Market
Japan

Shionogi & Co., Ltd. is a Japan-based pharmaceutical company mainly engaged in the research, development, purchase, manufacture and sale of pharmaceuticals, as well as pharmaceutical-related businesses. The prescription drug business is engaged in the development of eight new drugs including hypercholesterolemia treatment drugs Crestor, antihypertensive drugs Ilbetan Family (Irbetan, Aimix, Iltra) and antidepressant drugs Sinbalta. The Company is engaged in the provision of information to contribute to medical care by maximizing its products. The over-the-counter (OTC) pharmaceutical business handles products tailored to customers' lifestyles. The in-vitro diagnostics business is engaged in the sale of products, as well as the provision of information on infectious diseases, cardiovascular diseases and allergic diseases. The Company mainly provides its products and services in Japan, Europe and North America markets.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.